Jasper Therapeutics, Inc.JSPRNASDAQ
Loading
Stockholders Equity Over TimeContracting
Percentile Rank60
3Y CAGR-3.9%
5Y CAGR+23.9%
Year-over-Year Change
Net worth of the company (assets minus liabilities)
3Y CAGR
-3.9%/yr
Annual compound
5Y CAGR
+23.9%/yr
Recent deceleration
Percentile
P60
Within normal range
vs 5Y Ago
2.9x
Strong expansion
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2024 | $61.67M | -21.4% |
| 2023 | $78.44M | +118.0% |
| 2022 | $35.99M | -48.2% |
| 2021 | $69.52M | +297.9% |
| 2020 | $-35.13M | -266.5% |
| 2019 | $21.10M | - |